Abstract
The treatments used in postmenopausal women with advanced breast cancer include additive endocrine therapy. Due to the same or better efficacy as with other preparations and to the mild side effects, most authors now believe that the anti-oestrogen compound tamoxifen (TAM) is the drug of choice when additive endocrine treatment is indicated (Mouridsen et al., 1978; Tagnon, 1977).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ansfield, F. J., Davis, H. C., Jr., Ellerby, R. A., Ramireg, G.: A clinical trial of megesterol acetate in advanced breast cancer. Cancer 33, 907–910 (1974)
Barnes, D. M., Ribeiro, G. G., Skinner, L. G.: Two methods of measurements of oestradiol-17β and progesterone receptors in human breast cancer and correlation with response to treatment Eur. J. Cancer 13, 1133–1145 (1977)
Dæhnfeldt, J. L., Briand, P.: Determination of high affinity gestagen receptors in hormone responsive and hormone-independent GR mouse mammary tumors by an exchange assay. In: Progesterone receptors in normal and neoplastic tissues. McGuire, W. L., Raynaud, J.-P., Baulieu, E.-E. (eds.), p. 59. New York: Raven Press 1977
Goldenberg, I. S.: Clinical trials of testolactone, medroxy-progesterone-acetate and oxylone acetate in advanced female mammary cancer. A report of The Cooperative Breast Cancer Group. Cancer 23, 109–111 (1969)
Hayward, J.: Hormones and human breast cancer. Recent results in cancer research. Berlin, Heidelberg, New York: Springer 1970
Hayward, J. L., Carbone, P. P., Heuson, J.-C., Kumaoka, S., Segaloff, A., Rubens, R. D.: Assessment of response to therapy in advanced breast cancer. Eur. J. Cancer 13, 89–94 (1977)
Hsueh, A. J. W., Peck, E. J., Clark, J. H.: Progesterone antagonism of the estrogen receptor and estrogen-induced uterine growth. Nature 254, 337–339 (1975)
Hsueh, A. J. W., Peck, E. J., Clark, J. H.: Control of uterine estrogen receptor levels by progesterone. Endocrinologia 98, 438–444 (1976)
Kiang, D. T., Kennedy, B. J.: Tamoxifen (antiestrogen) therapy in advanced breast cancer. Ann. Intern. Med. 87, 687–690 (1977)
King, J. B.: Clinical relevance of steroid-receptor measurements in tumors. Cancer Treat. Rev. 2, 273–295 (1975)
Koseki, Y., Zava, D. T., Chamness, G. G., McGuire, W. L.: Estrogen receptor translocation and replenishment by the antiestrogen tamoxifen. Endocrinologia 101, 1104–1110 (1977)
Leclercq, G., Heuson, J.-C.: Therapeutic significance of sexsteroid hormone receptors in the treatment of breast cancer. Eur. J. Cancer 13, 1205–1217 (1977)
Lippman, M.: Hormone-responsive human breast cancer in continuous tissue culture. In: Breast cancer: trends in research and treatment. Heuson, J.-C., Mattheiem, W. H., Rozencweig, M. (eds.), p. 111. New York: Raven Press 1976
Manni, A., Trujillo, J., Marshall, J. S., Pearson, O. H.: Antiestrogen-induced remissions in stage IV breast cancer. Cancer Treat. Rep. 60, 1445–1450 (1976)
McGuire, W. L., Horwitz, K. B.: A role for progesterone in breast cancer. Ann. N.Y. Acad. Sci. 286, 90–100 (1977)
Milgrom, E., Luu This, M., Atger, M., Baulieu, E. E.: Mechanisms regulating the concentration and the conformation of progesterone receptors in the uterus. J. Biol. Chem. 248, 6366–6374 (1973)
Moseson, D. L., Sasaki, G. H., Kraybill, W. G., Leung, B. S., Davenport, C. E., Fletcher, W. S.: The use of antiestrogens tamoxifen and nafoxidine in the treatment of human breast cancer in correlation with estrogen receptor values. A phase II study. Cancer 41, 797–800 (1978)
Mouridsen, H. T., Palshof, T., Patterson, J., Battersby, L.: Tamoxifen in advanced breast cancer. Cancer Treat. Rev. 5, 131–141 (1978)
Muggia, F. M., Cassileth, P. A., Ochoa, Jr., M., Flatow, F. A., Gellhorn, A., Hyman, G. A.: Treatment of breast cancer with medroxyprogesterone-acetate. Ann. Intern. Med. 68, 328–337 (1968)
Nicholson, R. I., Golder, M. P., Davies, P., Griffiths, K.: Effects of estradiol-17/3 and tamoxifen on total and accessible cytoplasmic estradiol-17β receptors in DMBA-induced rat mammary tumors. Eur. J. Cancer 12, 711–717 (1976)
Palshof, T., Mouridsen, H. T., Dæhnfeldt, J.: Adjuvant endocrine therapy of breast cancer in premenopausal (placebo versus tamoxifen) and postmenopausal (placebo versus tamoxifen versus diethylstilboestrol) subjects In: Endocrine treatment of breast cancer. A new approach. Henningsen, B., Linder, F., Steichele, C. (eds.). Berlin, Heidelberg, New York: Springer 1980
Pannuti, F., Martoni, A., Lenaz, G. R., Piana, E., Nanni, P.: Management of advanced breast cancer with medroxyprogesteroneacetate (NSC 26386) in high doses. Functional exploration of serology, pp. 253–256 (1976)
Segaloff, A., Cuningham, M., Rice, B. F., Weeth, J. B.: Hormonal therapy in cancer of the breast. XIV — effect of corticosterone or medroxyprogesterone-acetate on the clinical course and hormonal excretion. Cancer 20, 1673–1688 (1967)
Stoll, B.: Progestin therapy of breast cancer: Comparison of agents. Br. Med. J. 1967a III, 338–341
Stoll, B.: Vaginal cytology as an aid to hormone therapy in postmenopausal cancer of the breast. Cancer 20, 1807–1813 (1967b)
Tagnon, H. J.: Antiestrogens in the treatment of breast cancer. Cancer 39, 2959–2964 (1977)
Tormey, D. C., Simon, R. M., Lippman, M. E., Bull, J. M., Myers, C. E.: Evaluation of tamoxifen dose in advanced breast cancer: A progress report. Cancer Treat. Rep. 60, 1451–1459 (1976)
Ward, H. W. C.: Combined antiprolactin and antiestrogen therapy for breast carcinoma. Clin. Oncol. 3, 91–95 (1977)
Wulf, H. R.: Confidence limits in evaluating controlled therapeutic trials. Lancet 1973 II, 969
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1980 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Mouridsen, H.T., Palshof, T., Rose, C. (1980). Therapeutic Effect of Tamoxifen Alone Versus Tamoxifen in Combination with Gestagen and Oestrogen in Advanced Breast Cancer. In: Henningsen, B., Linder, F., Steichele, C. (eds) Endocrine Treatment of Breast Cancer. Recent Results in Cancer Research / Fortschritte der Krebsforschung / Progrès dans les recherches sur le cancer, vol 71. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81406-8_26
Download citation
DOI: https://doi.org/10.1007/978-3-642-81406-8_26
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-81408-2
Online ISBN: 978-3-642-81406-8
eBook Packages: Springer Book Archive